±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1116  |  »Ø¸´: 9
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û2´Î£¬×÷ÕßzhaoyongqiangÔö¼Ó½ð±Ò 1.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


[×ÊÔ´] Reversed Phase Chromatography(ÍâÎÄÊé¼®)

ÏÂÔØµØÖ·http://www.namipan.com/d/Reverse ... 3e9f7057b6b0c7e0800

Contents
1. Introduction ..............................................................................................5
Theory of reversed phase chromatography ...............................................6
The matrix ................................................................................................9
The ligands ............................................................................................. 11
Resolution in reversed phase chromatography ........................................ 13
Resolution .............................................................................................. 13
Capacity factor ....................................................................................... 14
Efficiency ................................................................................................ 15
Selectivity ................................................................................................ 17
Binding capacity ..................................................................................... 18
Critical parameters in reversed phase chromatography........................... 19
Column length ...................................................................................19
Flow rate ............................................................................................19
Temperature ....................................................................................... 20
Mobile phase ..................................................................................... 20
Organic solvent .................................................................................. 20
Ion suppression .................................................................................. 21
Ion pairing agents .............................................................................. 22
Gradient elution ................................................................................. 23
Mode of use ............................................................................................24
Desalting ............................................................................................24
High resolution separations ............................................................... 25
Large scale preparative purification ................................................... 25
Stages in a purification scheme .......................................................... 26
Capture .............................................................................................. 26
Intermediate stages .............................................................................27
Polishing ............................................................................................27
2. Product Guide .........................................................................................29
SOURCE™ RPC ..................................................................................... 30
Product description ............................................................................ 30
High chemical stability ...................................................................... 32
Excellent flow/pressure characteristics ................................................ 34
High capacity ..................................................................................... 35
Availability ........................................................................................ 36
¦ÌRPC C2/C18 .........................................................................................37
Product description ............................................................................ 37
Chemical and physical stability .......................................................... 38
Flow/pressure characteristics ..............................................................38
Capacity ............................................................................................38
Availability ........................................................................................ 39
Sephasil™ Protein/Sephasil Peptide ......................................................... 39
Product description ............................................................................ 39
Chemical and physical stability .......................................................... 40
Flow/pressure characteristics ..............................................................40
Availability ........................................................................................ 40
3. Methods ................................................................................................. 41
Choice of separation medium .................................................................41
Unique requirements of the application .............................................. 41
Resolution .......................................................................................... 41
Scale of the purification ..................................................................... 42
Mobile phase conditions ....................................................................42
Throughput and scaleability ..............................................................42
Molecular weight of the sample components ......................................42
Hydrophobicity of the sample components ........................................ 43
Class of sample components ..............................................................43
Choice of mobile phase ........................................................................... 44
The organic solvent ............................................................................ 44
pH .....................................................................................................46
Ion pairing agents .............................................................................. 47
Sample preparation................................................................................. 49
Mobile phase preparation .......................................................................50
Storage of mobile phase ..................................................................... 50
Solvent disposal ................................................................................. 50
Detection ................................................................................................ 51
Ghosting ............................................................................................51
Mobile phase balancing ..................................................................... 51
Column conditioning .............................................................................. 52
Elution conditions ...................................................................................53
Column re-equilibration ......................................................................... 55
Column cleaning ..................................................................................... 55
Column storage ......................................................................................56
4. Applications............................................................................................57
Designing a biochemical purification ...................................................... 57
Naturally occurring peptides and proteins .............................................. 58
Purification of platelet-derived growth factor (PDGF) ........................ 59
Trace enrichment ............................................................................... 59
Purification of cholecystokinin-58 (CCK-58) from pig intestine ......... 60
Recombinant peptides and proteins ........................................................62
Process purification of inclusion bodies .............................................. 63
Purification of recombinant human epidermal growth factor ............. 63
Chemically synthesised peptides..............................................................65
Purification of a phosphorylated PDGF a-receptor derived peptide .... 65
Structural characterisation of a 165 kDa protein ............................... 66
Protein fragments from enzyme digests ................................................... 66
Protein characterisation at the micro-scale .........................................66
Protein identification by LC-MS ......................................................... 69
Chemically synthesised oligonucleotides ................................................. 70
5. Fault finding chart .................................................................................. 72
6. References ...............................................................................................81
7. Ordering information .............................................................................84

[ Last edited by zhaoyongqiang on 2008-3-17 at 12:07 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÔÂÁÁÍäÍä

½ð³æ (ÖøÃûдÊÖ)


½éÉÜһϱȽϺÃ
2Â¥2008-03-17 11:58:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

dnp

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

¼ûÊéÆÀÌû¡­¡­
3Â¥2008-03-17 11:59:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


¡¾ÆÀ¼Û¡¿  ¡ï¡ï¡ï¡ï¡ï (ÎåÐǼ¶,ÓÅÐãÍÆ¼ö)

¼ûÊéÆÀÌû¡­¡­
4Â¥2008-03-17 12:03:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

weifengnit

ľ³æ (ÕýʽдÊÖ)


Õâ¸öÒÔǰÌû¹ýÁ˵쬯äʵ¾ÍÊÇÒ»¸ö¹«Ë¾µÄ²úƷ˵Ã÷Êé¡£ÔÚ˵Ã÷ÊéÇ°Ãæ¼òµ¥µØ½éÉÜÁËһϷ´ÏàÉ«Æ×£¬¶øÕâЩ֪ʶ¶¼ÊÇ´ó¼ÒÊìϤµÄ¡£
5Â¥2008-03-17 13:48:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


ÒýÓûØÌû:
Originally posted by ruyibaobei at 2008-3-17 12:34:
ºÃ¶«¶«

¼ûÊéÆÀÌû¡­¡­
7Â¥2008-03-18 15:35:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


Ö§³Öһϣ¡
8Â¥2008-03-19 14:50:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


Ö§³Öһϣ¡
9Â¥2008-04-10 11:46:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
2008-03-17 15:01   »Ø¸´  
ÒýÓûØÌû:
Originally posted by weifengnit at 2008-3-17 13:48: Õâ¸öÒÔǰÌû¹ýÁ˵쬯äʵ¾ÍÊÇÒ»¸ö¹«Ë¾µÄ²úƷ˵Ã÷Êé¡£ÔÚ˵Ã÷ÊéÇ°Ãæ¼òµ¥µØ½éÉÜÁËһϷ´ÏàÉ«Æ×£¬¶øÕâЩ֪ʶ¶¼ÊÇ´ó¼ÒÊìϤµÄ¡£

Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ zhaoyongqiang µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] »¯¹¤µ÷¼Á303·Ö£¬¹ýËļ¶ +14 ÆÜÎà´ý·ç 2026-04-02 14/700 2026-04-02 21:58 by ¿ÆÑÐСר¼Ò
[¿¼ÑÐ] 312Çóµ÷¼Á +3 ÉÞÔÂÉ« 2026-04-02 4/200 2026-04-02 21:50 by macy2011
[¿¼ÑÐ] »·¾³¿ÆÑ§Ó빤³Ì334·ÖÇóµ÷¼Á +7 ÍõÒ»Ò»ÒÀÒÀ 2026-03-30 9/450 2026-04-02 21:15 by 1104338198
[¿¼ÑÐ] µ÷¼ÁÇóÖú +8 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 8/400 2026-04-02 20:47 by dongzh2009
[¿¼ÑÐ] 264·Ö£¬ÇóÈÎÒ⹤¿Æµ÷¼Á +4 zzlqwq 2026-03-29 5/250 2026-04-02 17:17 by ºÎÔø¼¸ºÎ
[¿¼ÑÐ] ²ÄÁÏ»¯¹¤340Çóµ÷¼Á +5 jhx777 2026-03-30 5/250 2026-04-02 12:45 by smileboy2006
[¿¼ÑÐ] 292Çóµ÷¼Á +14 ÊÇåû×ÓÒ²ÊÇÑÐ×Ó 2026-03-30 14/700 2026-04-02 10:17 by sanrepian
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +12 Ò»ÑùYWY 2026-04-01 12/600 2026-04-02 00:21 by °ÙÃë¹âÄê
[¿¼ÑÐ] 311Çóµ÷¼Á +10 ÀîÜÆÐÂ1 2026-03-31 10/500 2026-04-01 14:38 by chenqifeng666
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +7 @taotao 2026-03-30 7/350 2026-04-01 14:30 by chenqifeng666
[¿¼ÑÐ] 326Çóµ÷¼Á +4 áÌáÌ×Ð 2026-03-31 4/200 2026-04-01 09:58 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 070300»¯Ñ§×¨Òµ279µ÷¼Á +10 ¹þ¹þ¹þ^_^ 2026-03-31 10/500 2026-03-31 23:13 by liu823948201
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷½»´ó080500²ÄÁÏѧ˶349 +6 jqx1258 2026-03-31 7/350 2026-03-31 21:08 by yuq
[¿¼ÑÐ] 352·Ö-085602-Ò»Ö¾Ô¸985 +6 º£Äɰٴ¨Ly 2026-03-29 6/300 2026-03-31 21:06 by yuq
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +13 ÉîVËÞÉá°É 2026-03-29 13/650 2026-03-31 19:50 by Dyhoer
[¿¼ÑÐ] 085601Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ³õÊÔ346 +4 085601³õÊÔ346 2026-03-30 4/200 2026-03-31 07:47 by jp9609
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐʦ·¶»¯Ñ§332·ÖÇóµ÷¼Á +3 Lyy930824@ 2026-03-29 3/150 2026-03-30 20:15 by DHUSHUAI
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧ»¯Ñ§0703×Ü·Ö337Çóµ÷¼Á +6 niko- 2026-03-27 6/300 2026-03-30 10:25 by herarysara
[¿¼ÑÐ] 2026Ä껪ÄÏʦ·¶´óѧ»¶Ó­»¯Ñ§£¬»¯¹¤£¬ÉúÎÉúÒ½¹¤µÈרҵÓÅÐãѧ×Ó¼ÓÈ룡 +3 llss0711 2026-03-28 6/300 2026-03-29 10:26 by llss0711
[¿¼ÑÐ] 308Çóµ÷¼Á +7 īīĮ 2026-03-27 7/350 2026-03-28 07:43 by ÈÈÇéɳĮ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û